Core Viewpoint - The article discusses the industrialization project of Runhui Biotechnology (Weihai) Co., Ltd., focusing on the establishment of the Taimei Tai Pharmaceutical Formulation project, which aims to enhance production capabilities in the cosmetic and medical fields [2][3]. Project Overview - Project Name: Taimei Tai Pharmaceutical Formulation Industrialization Project - Construction Unit: Runhui Biotechnology (Weihai) Co., Ltd. - Nature of Construction: Expansion - Location: Existing factory area in Weihai, Shandong Province - Total Investment: 200 million yuan, fully self-funded by the company - Expected Production Start Date: June 2026 - Construction Content: New production workshops and procurement of over 140 pieces of equipment, including production lines for cosmetic raw liquids, recombinant human collagen, and sophorose [3][4]. Product Plan - **Cosmetic Raw Liquid**: Production capacity of 120 tons per year, packaged in 50 kg bags, for external sales - **Recombinant Human Collagen**: Production capacity of 600 kg per year, packaged in 2.5 kg bottles, for external sales - **Sophorose**: Production capacity of 50 tons per year, packaged in 25 kg bags, for external sales - The cosmetic raw liquid is designed to provide targeted skincare benefits with high concentrations of active ingredients [4][5]. Conference Information - The Fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [6][7]. - The conference will include various activities such as a youth forum, high-level discussions, and a closed-door seminar on the innovation development of the bio-manufacturing industry [6][15]. Key Participants and Activities - The conference will feature industry leaders and experts from various organizations, including universities and biotechnology companies, discussing trends and innovations in bio-manufacturing [15][38]. - Specific sessions will cover topics such as AI applications in bio-manufacturing, enzyme engineering, and the development of new functional sugars and bioproducts [39][42].